In consultation: Guidance and quality standards
Showing 11 to 14 of 14
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Oveporexton for treating type 1 narcolepsy [ID6622] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Ruxolitinib for treating moderate atopic dermatitis ID6602 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| NICE-wide Topic Prioritisation: the manual (PMG46) 2026 Update Consultation | Methods / process manual consultation | NICE process and methods | |
| Efgartigimod for treating chronic inflammatory demyelinating polyneuropathy [ID6409] | Draft guidance | Technology appraisal guidance |